Datum Källa Rubrik Typ Alternativ
2023-01-10 Promore Pharma BioStock: Promore Pharmas vd om förhoppningarna för 2023 Pressreleaser Visa Stäng
2023-01-10 Promore Pharma BioStock: Promore Pharma's CEO on hopes for 2023 Pressreleaser Visa Stäng
2022-12-08 Västra Hamnen Market Focus Västra Hamnen Market Focus: Promore Pharma: Inväntar resultat Analyser Visa Stäng
2022-11-29 Promore Pharma Interim report January - September 2022 Analyser Ladda ner | Visa Stäng
2022-11-29 Promore Pharma Delårsrapport januari – september 2022 Analyser Ladda ner | Visa Stäng
2022-11-24 Promore Pharma Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Third Quarter 2022 Analyser Ladda ner | Visa Stäng
2022-11-24 Promore Pharma Inbjudan till presentation av Promore Pharmas delårsrapport för Q3 2022 Analyser Ladda ner | Visa Stäng
2022-11-23 Promore Pharma Nomination Committee Appointed for the Annual General Meeting 2023 in Promore Pharma Analyser Ladda ner | Visa Stäng
Analyser | 23 Nov 2022 | Promore Pharma

Nomination Committee Appointed for the Annual General Meeting 2023 in Promore Pharma

STOCKHOLM, 23 November 2022 — Promore Pharma AB (publ) today announced the composition of the Nomination Committee for the Annual General Meeting 2023, which will be held on Tuesday 23 May 2023. The Nomination Committee shall, according to decided principles for the appointment of the Nomination Committee, consist of the Chairman of the Board and representatives for the three largest shareholders in the company.

The main task of the Nomination Committee is to submit proposals for Chairman of the Board and other members of the Board, remuneration for Board work, the election and remuneration of auditors. The Nomination Committee shall be composed of the Chairman of the Board and members appointed by the three largest shareholders in the company based on ownership of the Company as per the end of September 2022.

Accordingly, the following committee members have been appointed:

  • Marianne Dicander Alexandersson, Chairman of the Board
  • David Sundin, representing Corespring New Technology AB (former Midroc New Technology)
  • Candice Jung, representing PharmaResearch Co. Ltd
  • Jari Pulkkinen, representing a co-registered group of shareholders, with an ownership equivalent to 8.1% of the company

The Nomination Committee’s proposals will be presented in the Notice to the AGM 2023 and on the company web site, http://www.promorepharma.com . Shareholders desiring to submit comments or proposals to the nomination committee can send them via email to info@promorepharma.com .

2022-11-23 Promore Pharma Valberedning utsedd inför årsstämma 2023 i Promore Pharma Analyser Ladda ner | Visa Stäng
2022-11-15 Analysguiden Analysguiden: ANALYS Promore Pharma: Resultat från fas 2 mot ärrbildning i april 2023 Analyser Ladda ner | Visa Stäng
2022-11-01 Promore Pharma Promore Pharma uppdaterar om sin kliniska Fas II-studie med ensereptide Analyser Ladda ner | Visa Stäng
2022-11-01 Promore Pharma Promore Pharma provides an update on the Phase II clinical trial with ensereptide Analyser Ladda ner | Visa Stäng
2022-09-21 Promore Pharma BioStock: Promore Pharma's leg ulcer treatment to reduce patient suffering Pressreleaser Visa Stäng
2022-09-21 Promore Pharma BioStock: Promore Pharmas bensårsbehandling ska minska patientens lidande Pressreleaser Visa Stäng
2022-09-05 Promore Pharma BioStock: Promore Pharma advancing according to plan Pressreleaser Visa Stäng
2022-09-05 Promore Pharma BioStock: Promore Pharma avancerar enligt plan Pressreleaser Visa Stäng
2022-09-01 Västra Hamnen Market Focus Västra Hamnen Market Focus: Promore Pharma: Utvecklingsarbetet fortlöper Analyser Visa Stäng
2022-08-30 Promore Pharma Promore Pharma Interim report January – June 2022 Analyser Ladda ner | Visa Stäng
2022-08-30 Promore Pharma Promore Pharma Delårsrapport januari – juni 2022 Analyser Ladda ner | Visa Stäng
2022-08-23 Promore Pharma Invitation to Conference Call regarding Promore Pharma’s Interim Report for the Second Quarter 2022 Analyser Ladda ner | Visa Stäng
2022-08-23 Promore Pharma Inbjudan till telefonkonferens om Promore Pharmas rapport för det andra kvartalet 2022 Analyser Ladda ner | Visa Stäng
2022-08-15 Promore Pharma BioStock: Promore Pharma stärker patentskyddet Pressreleaser Visa Stäng
2022-08-15 Promore Pharma BioStock: Promore Pharma strengthens IP-protection Pressreleaser Visa Stäng
2022-08-10 Promore Pharma Promore Pharma granted EU patent regarding treatment of chronic wounds Analyser Ladda ner | Visa Stäng
2022-08-10 Promore Pharma Promore Pharma beviljas patent i Europa avseende behandling av kroniska sår Analyser Ladda ner | Visa Stäng
2022-06-17 Promore Pharma BioStock: Sista klinikbesöket genomfört i Promore Pharmas ensereptide-studie Pressreleaser Visa Stäng
2022-06-17 Promore Pharma BioStock: Last clinic visit completed in Promore Pharma's ensereptide study Pressreleaser Visa Stäng
2022-06-14 Analysguiden Analysguiden: ANALYS Promore Pharma: Rekryteringsmål uppnått i fas 2 mot ärrbildning Analyser Ladda ner | Visa Stäng
2022-06-13 Promore Pharma The last clinic visit conducted in Promore Pharma's phase II study of ensereptide Analyser Ladda ner | Visa Stäng
2022-06-13 Promore Pharma Sista klinikbesöket genomfört i Promore Pharmas fas II-studie av ensereptide Analyser Ladda ner | Visa Stäng
2022-05-25 Promore Pharma BioStock: Promore Pharma's Q1 characterised by study progress Pressreleaser Visa Stäng
2022-05-25 Promore Pharma BioStock: Promore Pharmas Q1 präglat av studieavancemang Pressreleaser Visa Stäng
2022-05-18 Västra Hamnen Market Focus Västra Hamnen Market Focus: Promore Pharma: Ärrstudie fullrekryterad Analyser Visa Stäng
2022-05-17 Promore Pharma Report from the Annual General Meeting of Promore Pharma AB held on 17 May 2022 Analyser Ladda ner | Visa Stäng
2022-05-17 Promore Pharma Kommuniké från Promore Pharma AB:s årsstämma den 17 maj 2022 Analyser Ladda ner | Visa Stäng
2022-05-17 Promore Pharma Promore Pharma -- delårsrapport januari-mars 2022 Analyser Ladda ner | Visa Stäng
2022-05-17 Promore Pharma Promore Pharma -- interim report January-March 2022 Analyser Ladda ner | Visa Stäng
2022-05-16 Promore Pharma BioStock: Promore Pharma vill påskynda läkning av venösa bensår Pressreleaser Visa Stäng
2022-05-16 Promore Pharma BioStock: Promore Pharma aims to accelerate healing of venous leg ulcers Pressreleaser Visa Stäng
2022-05-13 Promore Pharma Invitation to Conference Call regarding Promore Pharma’s Interim Report for the First Quarter 2022 Analyser Ladda ner | Visa Stäng
2022-05-13 Promore Pharma Inbjudan till telefonkonferens om Promore Pharmas rapport för det första kvartalet 2022 Analyser Ladda ner | Visa Stäng
2022-04-26 Promore Pharma Promore Pharmas årsredovisning för 2021 samt stämmohandlingar publicerade Analyser Ladda ner | Visa Stäng
2022-04-26 Promore Pharma Promore Pharma’s Annual Report 2021 and AGM related Documents Published Analyser Ladda ner | Visa Stäng
2022-04-12 Promore Pharma KALLELSE TILL ÅRSSTÄMMA I PROMORE PHARMA AB (PUBL) Analyser Ladda ner | Visa Stäng
2022-04-12 Promore Pharma NOTICE OF ANNUAL GENERAL MEETING PROMORE PHARMA AB (PUBL) Analyser Ladda ner | Visa Stäng
2022-04-07 Promore Pharma BioStock: Promore Pharmas fas II-studie pågår planenligt Pressreleaser Visa Stäng
2022-04-07 Promore Pharma BioStock: Promore Pharma's phase II study running according to plan Pressreleaser Visa Stäng

Kommande händelser

28 Feb 2023 | Bokslutskommuniké 2022
23 May 2023 | Årsstämma 2022